Navigation Links
Bypassing eggs, flu vaccine grown in insect cells shows promise

funded by the company of 460 healthy people ages 18 to 49, one-third of the participants received a smaller dose of the vaccine (75 micrograms), one-third received a larger dose (135 micrograms), and one-third received a placebo shot that didn’t include vaccine. Each of the “real?shots included vaccine designed to protect against the three strains of flu that had been predicted to be the greatest threat during the 2004-2005 winter, when the study was conducted.

As the scientists expected, both the smaller dose and the larger dose caused an immune reaction generally considered effective for fighting off the flu, with the larger dose creating a stronger immune response. The side effects of the vaccine were the same as those usually reported from a typical flu shot ?mainly mild arm pain.

Then, in the months that followed, there were seven cases of flu in the group that had not received the vaccine, compared to two cases in the group that received the smaller dose, and no cases in the group that received the larger dose. Together, the two vaccines reduced flu infection rate by 86 percent.

“Even though the study was small, the results are very promising,?said Treanor, who is professor of Medicine and of Microbiology and Immunology and director of the Vaccine and Treatment Evaluation Unit at the University of Rochester. “While we certainly hoped and expected the vaccine to be protective, you don’t know that until you actually test it. We’ve shown that the vaccine does work in the real world.?

Freedom from the egg brings implications important to a world facing the threat of pandemic bird flu.

For decades the nation’s efforts to prevent flu have centered on growing flu virus in hundreds of millions of fertilized eggs, with each egg containing less than a teaspoonful of material that will ultimately become part of a vaccine. It’s typically a six-month process to produce enough flu vaccine to protect the public.

Tak
'"/>

Source:University of Rochester Medical Center


Page: 1 2 3

Related biology news :

1. Technique may allow cancer patients to freeze eggs, preserving fertility before starting treatment
2. Research advances quest for HIV-1 vaccine
3. A much-needed shot in the arm for HIV vaccine development
4. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
5. Gene vaccine for Alzheimers disease shows promising results
6. Influenza vaccine uses insect cells to speed development
7. Norovirus, AIDS vaccine and Hepatitis Virus
8. HIV vaccine trial breaks ground for future research
9. Live vaccines more effective against horse herpes virus
10. NIAID begins clinical trial of West Nile virus vaccine
11. Designing vaccines by computer
Post Your Comments:
(Date:11/20/2008)...RGHResearch from the University of Pittsburgh publ...inally provide evidence of the first stages of the...that males and females developed from hermaphrodit...y understood because the majority of animal specie...arate-sex state too long ago for scientists to obs...
(Date:11/20/2008)... -- The body,s immune system hates strangers. When...hilates it. , This is the problem when people wi...lantation. The islet cells from a donor pancreas p... -- often permitting independence from insulin the... new hard-working islets. , A person who has the...
(Date:11/19/2008)...g virtual crime, treating an ageing population, an...ll be the focus of a 20 million ($30.4 million) in...ysical Sciences Research Council (EPSRC), Technolo...Biological Sciences Research Council (BBSRC). , ... areas where world-class scientific breakthroughs ...
(Date:11/19/2008)...sts at St. Jude Children,s Research Hospital have ...body,s enzyme workhorses called calpains. , As ...ion in many cellular processes, including the move...ls, insulin secretion, and brain cell and muscle f...ibilities is that defective or overactive calpains...
Breaking Biology News(10 mins):Two from one: Pitt research maps out evolution of genders from hermaphroditic ancestors 2Researcher tricks immune system in diabetic mice 2£20 million to fight virtual crime and treat our ageing population 2£20 million to fight virtual crime and treat our ageing population 3New insight into the controls on a go-to enzyme 2New insight into the controls on a go-to enzyme 3Aflac Incorporated Announces Third Quarter Results Declares Fourth Quarter Cash Dividend 4411 1Aflac Incorporated Announces Third Quarter Results Declares Fourth Quarter Cash Dividend 4411 2Aflac Incorporated Announces Third Quarter Results Declares Fourth Quarter Cash Dividend 4411 3Aflac Incorporated Announces Third Quarter Results Declares Fourth Quarter Cash Dividend 4411 4Aflac Incorporated Announces Third Quarter Results Declares Fourth Quarter Cash Dividend 4411 5Aflac Incorporated Announces Third Quarter Results Declares Fourth Quarter Cash Dividend 4411 6Aflac Incorporated Announces Third Quarter Results Declares Fourth Quarter Cash Dividend 4411 7Aflac Incorporated Announces Third Quarter Results Declares Fourth Quarter Cash Dividend 4411 8Aflac Incorporated Announces Third Quarter Results Declares Fourth Quarter Cash Dividend 4411 9Aflac Incorporated Announces Third Quarter Results Declares Fourth Quarter Cash Dividend 4411 10Aflac Incorporated Announces Third Quarter Results Declares Fourth Quarter Cash Dividend 4411 11Aflac Incorporated Announces Third Quarter Results Declares Fourth Quarter Cash Dividend 4411 12CV Therapeutics Announces Presentations at American Heart Association Scientific Sessions 2007 1448 1CV Therapeutics Announces Presentations at American Heart Association Scientific Sessions 2007 1448 2CV Therapeutics Announces Presentations at American Heart Association Scientific Sessions 2007 1448 3Phase I Results Announced for R1507 From Genmabs Collaboration With Roche 1445 1Phase I Results Announced for R1507 From Genmabs Collaboration With Roche 1445 2Phase I Results Announced for R1507 From Genmabs Collaboration With Roche 1445 3Tapestry Pharmaceuticals Presents Data on TPI 287 at the AACR NCI EORTC International Conference on Molecular Targets and Cancer Therapeutics 617 1Tapestry Pharmaceuticals Presents Data on TPI 287 at the AACR NCI EORTC International Conference on Molecular Targets and Cancer Therapeutics 617 2Tapestry Pharmaceuticals Presents Data on TPI 287 at the AACR NCI EORTC International Conference on Molecular Targets and Cancer Therapeutics 617 3Tapestry Pharmaceuticals Presents Data on TPI 287 at the AACR NCI EORTC International Conference on Molecular Targets and Cancer Therapeutics 617 4
...erstanding how the human brain learns to perceive ...science. In 2003, Pawan Sinha, a professor at the...n initiative with the hopes of shedding some light...his "Project Prakash" is to find, treat, and study...ase study that resulted from this project appears ...
...entists at Queensland University of Technology are...ne to protect women against contracting the most c...nternational vaccine company Sanofi-Pasteur has aw... continue its research into Chlamydia and work tow...dolescent women. , Professor Peter Timms, from ...
... regions of the brain that control vision and othe...st few months following birth, while the area that... growth during the same period, University of Nort..., The researchers discovered that the back regions...tegration, grew significantly faster than the pref...
...may not be as fit as the people of ancient Athens,...vide, according to research by University of Leeds...Dr Rossiter measured the metabolic rates of modern...rireme, a 37m long warship powered by 170 rowers s...lysers, he measured the energy consumption of a sa...
Other Biology News:Chlamydia vaccine a step closer to reality 2Newborn brains grow vision and movement regions first 2Newborn brains grow vision and movement regions first 3Fitness has fallen since the days of Ancient Greece 2
(Date:11/20/2008)...PRNewswire-FirstCall/ -- Par Pharmaceutical Compan...U.S. District Court for the District of New Jersey...otion for a temporary restraining order (TRO) halt...(budesonide inhaled solution). In conjunction wit...ed and that it too would halt all sales of its aut...
(Date:11/20/2008)...FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL ),ann...IVO QUALITY and iScale,Oligos(TM) siRNA. MISSION(...,expected to allow researchers to successfully ta...highest purity and quality siRNA required for RNAi...ved to be well suited to target,validation and pr...
(Date:11/20/2008)...re/ -- KansasBio announced today a,bioscience clu... human,health-care-related bioscience companies t...Called the National Drug Development Accelerator (...s across Kansas and the Kansas,City metropolitan ... resources,for drug development. , KansasB...
(Date:11/20/2008)...- IDRI (Infectious Disease Research,Institute) an...ve entered into,an agreement pursuant to which Im...e license for the research, development, and comme...ant (GLA) technology for products targeting a,num...ht infectious diseases of,the developing world, I...
Breaking Biology Technology:Par Pharmaceutical Halts Shipment of Budesonide Inhalation Suspension 2Sigma-Aldrich Introduces MISSION(R) In VIVO QUALITY and iScale Oligos(TM) siRNA, a Superior Quality siRNA Designed for RNAi Research in Animal Models 2National Drug Development Accelerator Launched 2IDRI and Immune Design Corp. Enter License Agreement on GLA Vaccine Adjuvant 2
...ble to understand why animal-rights advocates pass...one likes to see another creature suffer needlessl...ut animal-based research that run counter to the i...ose who recently targeted the homes of researchers...animal research and its benefits for humans and a...
...ences and the high density of activities occurring...ling columnist takes you north of the border to Ca...the Toronto Biotechnology Initiative . , ,You may...ust recently returned from Israel. The Illinois Tr...nt of Commerce & Economic Opportunity, is trying t...
... Click here to read part one . , , You or your...e perceived need to be concerned with patent matte...that consider enforcing patents to be a main or si...e and more businesses have to be concerned with pa...end licensing letters or to file lawsuits against ...
...been awarded the top ranking for a mid-size city i...al Cities Survey, an annual review of how city gov... annual survey is conducted by the Center for Digi...yofmadison.com , allows visitors access to feature...gs and proposed legislation, paying property taxes...
Other Biology Technology:Animal testing: Beyond the protests, instances of mistreatment are rare 2Animal testing: Beyond the protests, instances of mistreatment are rare 3Take off: Canadian biotech industry thrives 2Take off: Canadian biotech industry thrives 3Take off: Canadian biotech industry thrives 4Guarding against patent enforcement 2Guarding against patent enforcement 3Guarding against patent enforcement 4
Candida (IgG) -Ab EIA Sample Size: 5 l
... LDL (Competitive) EIA Principle: The Oxidized L...tibody 4E6. Oxidized LDL in the sample competes wi...rotiter well for the binding of the biotin- labele...ize: 25 l The Oxidized LDL Competitive Enzyme-Li...
ShortCut RNase III, used with its manganese-containing reaction buffer, converts long double-stranded RNA into a heterogeneous mix of short (1825 bp) interfering RNAs (siRNA) suitable for RNA interfe
For cleavage of 6xHis tags from proteins containing a Factor Xa Protease recognition site Efficient 6xHis tag cleavage (greater than 90%),
Biology Products: